Taking the kidney to heart.
Yinn Shaung OoiWilliam A GrayPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
Growing evidence supports the role of Impella in the prevention of acute kidney injury in high-risk percutaneous interventions (HR-PCIs). The Mehran contrast-induced nephropathy risk score may serve as a helpful risk stratification tool in discerning patients undergoing HR-PCI who may benefit from renal protection with Impella support. Further research is warranted to validate this renal protection strategy.
Keyphrases
- patients undergoing
- extracorporeal membrane oxygenation
- coronary artery disease
- atrial fibrillation
- high glucose
- heart failure
- magnetic resonance
- acute myocardial infarction
- percutaneous coronary intervention
- acute coronary syndrome
- left ventricular assist device
- diabetic rats
- drug induced
- st elevation myocardial infarction
- magnetic resonance imaging
- coronary artery bypass grafting
- computed tomography
- endothelial cells
- radiofrequency ablation